Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) EBT Margin (2023 - 2025)

Mereo BioPharma (MREO) has disclosed EBT Margin for 2 consecutive years, with 25085.71% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin changed N/A to 25085.71% in Q3 2025 year-over-year; TTM through Sep 2025 was 14237.33%, a 965263.0% decrease, with the full-year FY2023 number at 299.98%, changed N/A from a year prior.
  • EBT Margin was 25085.71% for Q3 2025 at Mereo BioPharma, up from 2923.2% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 25085.71% in Q3 2025 to a low of 2923.2% in Q2 2025.